Latest News
FDA Grants Accelerated Approval for Jazz Pharmaceutical's Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma
Details >CMS Expands Access to Life Saving Gene Therapies Through Innovative State Agreements
Participating states to test outcomes-based payments for sickle cell disease treatments, improving care while lowering long-term costs
Details >Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!